Accretion Nutraveda Reports Robust H1 FY27 Performance with Revenue Doubling YoY
Accretion Nutraveda Ltd · Investor Presentation · 03 Nov 2026, 11:29 pm
Accretion Nutraveda Reports Robust H1 FY27 Performance with Revenue Doubling YoY Accretion Nutraveda Limited reported robust financial results for H1 FY27, with total income from operations surging 109.35% YoY to ₹29.44 crore. EBITDA rose 88.03% YoY to ₹6.26 crore with a 21.27% margin, while PAT increased 98.66% YoY to ₹4.73 crore (16.06% margin), translating to an EPS of ₹6.53. Net worth expanded to ₹40.2 crore as of 30th Sep'26. Growth was driven by broad-based demand across Ayurvedic and nutraceutical segments, supported by CDMO services, brand exports, and ongoing capacity and automation expansions.
Original exchange filing (PDF)
More announcements from Accretion Nutraveda Ltd
- Intimation wrt change in Corporate Office address of Kfin Technologies Limited (RTA) with effective from 01st December, 2026 · 16 Nov 2026
- Intimation regarding update of corporate Identification Number (CIN) of the Company. · 03 Nov 2026
- Accretion Nutraveda Limited inform the stock exchange regarding press release dated 31st October, 2026 · 01 Nov 2026
- Please find enclosed herewith Outcome of the Board Meeting dated 31st October, 2026 · 01 Nov 2026
- Accretion Nutraveda Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2026 ,inter alia, to consider and approve Please find enclosed herewith .... · 31 Oct 2026
- Please find enclosed herewith intimation w.r.t Amendments to Memorandum of Association · 11 Oct 2026
- Please find enclosed herewith with respect to Board Meeting update · 02 Sept 2026
- Please Find enclosed herewith with respect to Board Meeting update · 01 Sept 2026
